U.S. Markets closed

Teva Pharmaceutical: Still Focused on New Product Launches

Sarah Collins
Teva Pharmaceutical: Still Focused on New Product Launches

Can Teva Pharmaceutical's Restructuring Plan Help It Recuperate? The Vanguard Total International Stock ETF (VXUS) holds 0.09% of its total portfolio in TEVA stock. Teva Pharmaceutical Industries (TEVA) has its biggest value chain in the market as the company’s core strength, which has helped it establish itself as the leading generics pharmaceutical company in the world.